Luo, X., Cai, S., Li, Y., Li, G., Cao, Y., Ai, C., . . . Li, T. (2020). Drp-1 as Potential Therapeutic Target for Lipopolysaccharide-Induced Vascular Hyperpermeability. Oxid Med Cell Longev.
Chicago Style CitationLuo, Xu, Shumin Cai, Yunfeng Li, Guicheng Li, Yuanyuan Cao, Chenmu Ai, Youguang Gao, and Tao Li. "Drp-1 As Potential Therapeutic Target for Lipopolysaccharide-Induced Vascular Hyperpermeability." Oxid Med Cell Longev 2020.
MLA CitationLuo, Xu, et al. "Drp-1 As Potential Therapeutic Target for Lipopolysaccharide-Induced Vascular Hyperpermeability." Oxid Med Cell Longev 2020.
Warning: These citations may not always be 100% accurate.